Engineered NIR-Responsive Exosomes for Synergistic Photoimmunotherapy of Hepatocellular Carcinoma
ACS Omega · 24.06.2025 · 10 (24) · 25675-25685
DOI: 10.1021/acsomega.5c01396 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 11.06.2025. Verfasst von Youbo Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Center for Tissue Engineering and Stem Cell Research, Gui…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Outstanding Youth Foundation of Jiangsu Province.
Abstract (Originalsprache)
T-cell immunotherapy holds tremendous promise for treating various types of cancer by boosting the infiltration and activity of T cells within tumor tissues. However, efficient recruitment of peripheral T cells to the tumor microenvironment (TME) remains a major clinical challenge. To address this limitation, here, we report an exosomal (EXO) immunotherapy for remodeling the immunosuppressive TME of hepatocellular carcinoma (HCC) into an immunosupportive state in a remotely controllable manner, for which the HCC-secreted exosomes are engineered with CXCL9 chemokine and cypate photothermal transducers (cypate@EXO-CXCL9). The engineered exosomes could efficiently home to the HCC site through homotypic targeting. Upon exposure to near-infrared light, the cypate-mediated photothermal effect readily induces immunogenic death of tumor cells while simultaneously disrupting the exosomes to release CXCL9. The released CXCL9 effectively attracts T cells to the tumor site and is subsequently activated by the HCC-derived antigens and damage associated molecular patterns to mount robust antitumor immunity. This study provides a facile strategy for the remodeling of the immunosuppressive HCC microenvironment, offering an approach for improving immunotherapeutic efficacy of solid tumors in the clinic.
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang…
- Guizhou Provincial Institute of Hepatobiliary, Pancreatic and Splenic Diseases, No. 28 Guiyi Street, Yunyan District, Guiyang 550001, P. R. China.
- College of Pharmaceutical Sciences, Soochow University, No. 199 Ren'ai Road, Industrial Park District, Suzhou 215123, P. R. China.
- School of Life Science, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, P. R. China.
- School of Mechanical Engineering, Suzhou University of Science and Technology, No. 1 Kerui Road, High-Tech District, Suzhou 215009, P. R. China.
ORCID-Profile: Menghuan Li
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Outstanding Youth Foundation of Jiangsu Province
- Guizhou Province Clinical Medical Research Center for Hepatobiliary Surgery
- Affiliated Hospital, Guizhou Medical University
- Guizhou Province
- Jiangsu Provincial Excellent Postdoctoral Program
Zitieren
APA
Zhao, Y., Li, Y., He, Z., Li, M., Zhao, D., & Yu, C. (2025). Engineered NIR-Responsive Exosomes for Synergistic Photoimmunotherapy of Hepatocellular Carcinoma. ACS Omega, 10(24), 25675-25685. https://doi.org/10.1021/acsomega.5c01396
Vancouver
Zhao Y, Li Y, He Z, Li M, Zhao D, Yu C. Engineered NIR-Responsive Exosomes for Synergistic Photoimmunotherapy of Hepatocellular Carcinoma. ACS Omega. 2025;10(24):25675-25685. doi:10.1021/acsomega.5c01396
BibTeX
@article{Zhao2025,
author = {Zhao, Youbo and Li, Yanan and He, Zhiwei and Li, Menghuan and Zhao, Di and Yu, Chao},
title = {Engineered NIR-Responsive Exosomes for Synergistic Photoimmunotherapy of Hepatocellular Carcinoma},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {24},
pages = {25675--25685},
doi = {10.1021/acsomega.5c01396}
}
EUVIMED